9 December 2022 false No description of principal activity Taxfiler 2023.14 14532576business:PrivateLimitedCompanyLtd2022-12-092023-12-31 145325762022-12-08 145325762022-12-092023-12-31 14532576business:AuditExempt-NoAccountantsReport2022-12-092023-12-31 14532576business:FilletedAccounts2022-12-092023-12-31 145325762023-12-31 14532576business:Director12022-12-092023-12-31 14532576business:RegisteredOffice2022-12-092023-12-31 14532576core:WithinOneYear2023-12-31 14532576core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 14532576core:PreviouslyStatedAmount2023-12-31 14532576business:SmallEntities2022-12-092023-12-31 14532576countries:EnglandWales2022-12-092023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 14532576 (England and Wales)
WAHIDIPHARMA LTD Unaudited accounts for the period from 9 December 2022 to 31 December 2023
WAHIDIPHARMA LTD Unaudited accounts Contents
Page
- 2 -
WAHIDIPHARMA LTD Company Information for the period from 9 December 2022 to 31 December 2023
Director
Ahmad-Zubair Wahidi
Company Number
14532576 (England and Wales)
Registered Office
3 COLYERS LANE ERITH DA8 3NG ENGLAND
Accountants
PRIME ACCOUNTANTS 10 LOCKWOOD HOUSE LOCKWOOD PARK HUDDERSFIELD HD4 6EN
- 3 -
WAHIDIPHARMA LTD Statement of financial position as at 31 December 2023
2023 
Notes
£ 
Current assets
Cash at bank and in hand
3,620 
Creditors: amounts falling due within one year
(3,619)
Net current assets
1 
Net assets
1 
Capital and reserves
Called up share capital
1 
Shareholders' funds
1 
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 4 March 2023 and were signed on its behalf by
Ahmad-Zubair Wahidi Director Company Registration No. 14532576
- 4 -
WAHIDIPHARMA LTD Notes to the Accounts for the period from 9 December 2022 to 31 December 2023
1
Statutory information
WAHIDIPHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 14532576. The registered office is 3 COLYERS LANE, ERITH, DA8 3NG, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2023 
£ 
Taxes and social security
312 
Loans from directors
3,307 
3,619 
5
Average number of employees
During the period the average number of employees was 2.
- 5 -